913 / 1224
/
/
Multi-center analysis:
King et al Radiat Oncol 2013
Risk-group Follow-
up
Low
36 mo
Intermediate 31 mo
High
23 mo
1100 patients
8 institutions
All patients enrolled in
phase II studies
Matthias Guckenberger - DEGRO 2015
24
Promising results in all risk groups but FU still short
Very few patients in the high-risk group and no further information
about detailed risk
13.06.2016